Skip to main content
. Author manuscript; available in PMC: 2015 Feb 5.
Published in final edited form as: J Allergy Clin Immunol. 2009 Feb 28;123(6):1376–83.e7. doi: 10.1016/j.jaci.2009.01.049

Table I. Characteristics of Study Population(26).

Flunisolide
(n=416)
Non Flunisolide**
(n=99)
White (US Caucasian) 362 88
Black (African American) 26 8
Other* 28 3
Age [Y (mean ±SD)] 39.9 ± 13.7 40.7 ± 13.5
Sex (% Male) 41.8 41.4
Asthma duration [Y (mean ±SD)] 20.7 ± 14.2 21.1 ± 12.7
Pack years (mean ±SD) 5.6 ±7.7 7.4 ±7.8
Subjects completing 8-week study 348 91
*

Asian, Hispanic, Native American

**

triamcinolone, beclomethasone, or fluticasone propionate

HHS Vulnerability Disclosure